Rehabtronics

Recover Mobility, Cognition and Confidence.

Rehabtronics develops medical devices that restore function and improve the lives of people who are paralyzed or immobile. Founded in 2003 as a spinoff from the Neuroscience Institute of the University of Alberta, Rehabtronics is dedicated to bringing neuroscience discoveries into clinical practice.

The company’s newest product, Prelivia is designed to alleviate pressure injuries, one of the deadliest hospital-acquired injuries. It is the first innovation in 70 years aimed to protect patients from pressure injuries. Prelivia proprietary neurostimulation that is scientifically proven to stimulate blood circulation and minimize tissue damage.

We offer a suite of scientifically designed products that help patients recover from stroke or neural injuries. Clinically proven, quick to set up and easy to use, patients can now get a grip on their own recovery.

After a stroke or neural injury, patients with restricted mobility and independence need help to regain range of movement and improve cognition. These products have been clinically proven to speed their recovery and maintain their ability to move freely.

Three decades of science and clinical trials have gone into the development of our rehabilitation products that help people regain mobility and improve cognition. Hundreds of clinics around the world are successfully using our products. We actively collaborate with universities and health organizations to continually refine and improve their performance.

The ReGrasp bionic glove can be controlled either by head movement or a simple tap on the wrist control panel. It helps reeducate muscles, increases circulation, reduces muscle spasms and helps paralyzed fingers to move through functional electrical stimulation (FES). Not yet available in Canada.

We’re on a mission to improve the lives of people with mobility impairments using neuroscience innovations.

Our Rehab devices are proven to help people recover movement after central or peripheral nervous system injury or disease. Hundreds of clinics around the world use our products for rehabilitation.

Prelivia, our new product, uses our patented neuro stimulation technology to help alleviate pressure injuries. Also commonly known as bedsores, pressure injuries affect up to 2.5 million patients in North America each year and are considered one of the most expensive and deadly hospital-acquired injuries. Prelivia is the first technology designed to prevent damage by restoring blood circulation and tissue oxygenation.

Rehabtronics is driven by a vision to transform healthcare with technology innovation. The company began as a spinoff from the Neuroscience and Mental Health Institute of the University of Alberta. Our founders saw an opportunity to bring its neural rehabilitation discoveries into clinical practice to help patients recover from Stroke, Spinal Cord, and other Neurological Injuries. We continue to develop and validate our devices in partnership with research institutions and initiatives around the world.

Rehabtronics owns patents relating to hand/arm neuro prosthetic devices, and hands-free control thereof using various head movements. Our company also owns patents relating to telerehabilitation and delivery of physical therapy over the Internet, the digital automation of arm and hand function assessment, and the use of IES for the prevention of pressure injuries.

Davie  Mendelsohn

Davie Mendelsohn

  • VP Sales, North America
Don  Wright

Don Wright

  • CFO: Chief Financial Officer
  • CMA
  • CPA
Bojana  Turic

Bojana Turic

  • Chief Scientific Officer (CSO)
Rahul  Samant

Rahul Samant

  • Chief Executive Officer (CEO)